101
|
Eaton J, Murrell Z, Cornwall G, James S. The impact of a rotating short-term partnership model on burden of
surgical disease in Rural Kenya: one team’s three-year experience. Ann Glob Health 2016. [DOI: 10.1016/j.aogh.2016.04.155] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
102
|
Chapman K, James S. A review of results from patient experience surveys during the introduction of group pre-radiotherapy patient information sessions. Radiography (Lond) 2016. [DOI: 10.1016/j.radi.2016.01.003] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
103
|
Angela S, Camaioni C, Bohnen S, Khanji MY, Hilbert S, Goetschalckx K, Calvieri C, Reinstadler SJ, Maestrini V, James S, Bastiaenen R, Reid AB, Amadu A, Pontone G, Alberto C, Manuel DL, Federico M, Francesca P, Bendetta G, Giorgio DC, Giuseppe T, Luisa C, Emanuele B, Domenico C, Sabino I, Martina PM, Morlon L, Vergé MP, Jais P, Roudaut R, Laurent F, Lafitte S, Cochet H, Réant P, Radunski UK, Lund GK, Senel M, Avanesov M, Tahir E, Stehning C, Adam G, Blankenberg S, Muellerleile K, Balawon A, Boubertakh R, Petersen SE, Spampinato R, Oebel S, Hindricks G, Bollmann A, Jahnke C, Paetsch I, Bogaert J, Desmet W, Toth A, Merkely B, Janssens S, Claus P, Preda MB, Perfetti A, Valaperta R, Secchi F, Fedele F, Martelli F, Lombardi M, Eitel C, Fuernau G, de Waha S, Desch S, Mende M, Metzler B, Schuler G, Thiele H, Eitel I, Mun HC, Kotwinski P, Rosmini S, Sanders J, Lloyd G, Dudley JP, Kellman P, Hugh EM, Manisty C, James CM, Waterhouse D, Murphy T, Kenny C, O'Hanlon R, Cox AT, Wijeyeratne Y, Colbeck N, Pakroo N, Ahmed H, Bunce N, Anderson L, Prasad S, Sharma S, Behr ER, Miller C, Jovanovic A, Woolfson P, Abidin N, Schmitt M, Rodrigues J, Dastidar AG, Baritussio A, Lawton C, Venuti G, Meloni G, Conti M, Bucciarelli-Ducci C, Andreini D, SoLbiati A, Guglielmo M, Mushtaq S, Baggiano A, Beltrama V, Rota C, Guaricci AI, Pepi M. ORAL AB QUICK FIRE I1496Myocardial substrates underlyng early ventricular arrhythmias in st-elevation acute myocardial infarction: the role of cardiac magnetic resonance1416Cardiac magnetic resonance predicts atrial fibrillation occurrence in patients with hypertrophic cardiomyopathy1469T1 and T2 mapping cardiovascular magnetic resonance to monitor inflammatory activity in patients with myocarditis1480Impact of electronic coaching on cardiovascular risk reduction in a high-risk primary prevention population – A cardiovascular magnetic resonance sub-study1598Anatomical and functional evaluation of postinterventional pulmonary vein stenosis by magnetic resonance imaging1364Reduced infarct-adjacent wall thickening and impaired restperfusion in the area at risk of successfully reperfused acute myocardial infarction1580Correlation between circulating microRNA 29 and diffuse myocardial fibrosis, assessed by T1 mapping, in patients affected by non ischemic dilative cardiomyopathy1435Association of Smoking with Myocardial Injury and Clinical Outcome in Patients Undergoing Mechanical Reperfusion for ST-Elevation Myocardial Infarction1640Assessing the risk of late cardiotoxicity in low risk breast cancer survivors receiving contemporary anthracycline treatment: a 6 year 100 patient study1511Risk stratification in sarcoidosis: Incidence of cardiac sarcoidosis in individuals diagnosed with extra-cardiac disease by cardiovascular magnetic resonance1334Patterns of late gadolinium enhancement in Brugada syndrome1591Detailed Left Atrial Assessment in Anderson Fabry Disease1634Role of cardiac magnetic resonance in the diagnosis of ARVC/D mimics1321Comparison of transtlioracic ecliocardiography versus cardiac magnetic for implantable cardioverter defibrillator therapy in primary prevention strategy dilated cardiomyopathy patients: Table 1. Eur Heart J Cardiovasc Imaging 2016. [DOI: 10.1093/ehjci/jew179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
104
|
Hylton B, Lidder S, Armitage A, James S. Eastbourne Miami-J Protocol: a Pilot Study for the Care of Cervical Injuries in the Community. ACTA CHIRURGIAE ORTHOPAEDICAE ET TRAUMATOLOGIAE CECHOSLOVACA 2016; 83:186-188. [PMID: 27484077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
UNLABELLED PURPOSE OF THE STUDY The aim of this pilot study was to develop The Eastbourne Miami-J Protocol for care of cervical injuries within the community. Led by orthopaedic senior practitioners, a multidisciplinary approach was developed to provide education and collar care for patients on a weekly basis. MATERIALS AND METHODS A total of 51 patients (17 male and 33 female), mean age 74 years (21 to 95) with CT confirmed cervical injuries during November 2010 and May 2014 followed the Eastbourne Miami-J Protocol. RESULTS Patients required collar care on average for 7.25 weeks. Thirty-two patients had single level cervical injuries with C2 the commonest. Complications included: 6 patients with psychosocial issues; 10 patients with skin erythema due to ill-fitting collars and 2 patients with skin breakdown requiring dressings. CONCLUSION The Eastbourne Miami-J protocol demonstrates that a multidisciplinary approach, championed by the casting department, can provide care for patients with cervical injuries within the community. KEY WORDS cervical spine, C-spine, cervical collar, community, rehabilitation.
Collapse
|
105
|
Johnson-Lawrence VD, James S. Is Higher Education Protective against Obesity in the Face of Discrimination? Int J Epidemiol 2015. [DOI: 10.1093/ije/dyv096.570] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
106
|
Cunningham S, Hall A, Jackson A, Jarrett-Smith L, Rees P, Brennan C, Saeed Y, Ng F, Kirkwood G, Orini M, Lambiase P, Srinivasan N, Walker N, Wright G, Goodwin J, Reilly J, Connelly D, Mudd P, Wilson C, Rice A, Iglesias A, Taggart S, James S, Thornley A, Turley A, Linker N, Rashid-Fadel T, Bond R, Rosengarten J, Thomas G, Butcher C, Lysitsas D, Wong T, Markides V, Jones D, Hussain W, Gilmore M, Barry J, Srinivasan N, Patel K, Lowe M, Segal O, Temple I, Borbas Z, Atkinson A, Yanni J, Yanni J, Boyett M, Garratt C, Dobrzynski H, Roney C, Debney M, Eichhorn C, Nachiappan A, Qureshi N, Chowdhury R, Kanagaratnam P, Lyon A, Peters N, Lawless M, Pearman C, Radcliffe E, Caldwell J, Trafford A, Taggart P, Hanson B, Hayward M, Lambiase PD, Yanni J, Orini M, Hanson B, Hayward M, Smith A, Zhang H, Dobrzynski H, Boyett M, Taggart P, Orini M, Simon R, Providencia R, Babu G, Vyas S, Khan F, Chow T, Segal O, Lowe M, Lambiase P. Allied Professionals. Europace 2015; 17:v3-v5. [PMCID: PMC4892104 DOI: 10.1093/europace/euv325] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2023] Open
|
107
|
Hunter J, James S, Chan D, Stacey B, Stroud M, Patel P, Cummings F, Fine D. OC-008 Virtual inflammatory bowel disease clinics in the real world. Gut 2015. [DOI: 10.1136/gut.2009.208934h] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/17/2023]
|
108
|
James S, Waterhouse D, Murphy T, Kenny C, Wilkinson M, O’Connell E, Gallagher J, Watson C, O’Hanlon R, Ledwidge M, McDonald K. 56 Comparison of morbidity, mortality and cost impact of stage B and stage C heart failure underline the clinical and economic need for national heart failure prevention strategy. BRITISH HEART JOURNAL 2015. [DOI: 10.1136/heartjnl-2015-308621.56] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
109
|
James S, Gallagher J, Kenny C, Waterhouse D, McCambridge J, Murphy T, O’Connell E, Ledwidge M, Watson C, Harkins V, McDonald K. 36 High prevalence of asymptomatic left ventricular dysfunction despite excellent risk factor control in a diabetic cohort. BRITISH HEART JOURNAL 2015. [DOI: 10.1136/heartjnl-2015-308621.36] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
110
|
James S, Murphy T, Waterhouse DF, Gallagher J, O’Connell E, Barton D, McDonald K. 22 Role of 12-lead electrocardiography in predicting heart failure in the community. BRITISH HEART JOURNAL 2015. [DOI: 10.1136/heartjnl-2015-308621.22] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
111
|
Murphy T, Waterhouse FD, James S, Kenny C, O’Hanlon R. 15 Incidence of cardiac sarcoidosis in those with extra-cardiac disease without known cardiac involvement – a CMR study. BRITISH HEART JOURNAL 2015. [DOI: 10.1136/heartjnl-2015-308621.15] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
112
|
Murphy T, Watershouse D, James S, O’Hanlon R, Gallagher J, Legwidge M, McDonald K, Kenny C. 37 Clinical workload in a DMP in the first three months post discharge and comparison of hfref and HFpEF. BRITISH HEART JOURNAL 2015. [DOI: 10.1136/heartjnl-2015-308621.37] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
113
|
Okawa M, Tateshima S, James S, Szeder V, Gonzalez N, Jahan R, Duckwiler G. E-109 predictors of poor outcome in aneurysm ruptures during embolization. J Neurointerv Surg 2015. [DOI: 10.1136/neurintsurg-2015-011917.184] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
114
|
Chen H, Fiuza F, Link A, Hazi A, Hill M, Hoarty D, James S, Kerr S, Meyerhofer DD, Myatt J, Park J, Sentoku Y, Williams GJ. Scaling the yield of laser-driven electron-positron jets to laboratory astrophysical applications. PHYSICAL REVIEW LETTERS 2015; 114:215001. [PMID: 26066440 DOI: 10.1103/physrevlett.114.215001] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/29/2015] [Indexed: 06/04/2023]
Abstract
We report new experimental results obtained on three different laser facilities that show directed laser-driven relativistic electron-positron jets with up to 30 times larger yields than previously obtained and a quadratic (∼E_{L}^{2}) dependence of the positron yield on the laser energy. This favorable scaling stems from a combination of higher energy electrons due to increased laser intensity and the recirculation of MeV electrons in the mm-thick target. Based on this scaling, first principles simulations predict the possibility of using such electron-positron jets, produced at upcoming high-energy laser facilities, to probe the physics of relativistic collisionless shocks in the laboratory.
Collapse
|
115
|
Harris R, Beardmore C, Bolderston A, James S, Probst H, Bennett C, Bostock S, Downs C, Faithfull S, Hoy S, Scott A, Tait D, Trueman E, Wells M. EP-1678: Practice Guidelines skin care advice for patients undergoing radical external beam megavoltage radiotherapy. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)41670-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
116
|
Steiner F, Evans J, Marsh R, Rigby P, James S, Sutherland K, Wickens R, Nedev N, Kelly B, Tan S. Mouth opening and trismus in patients undergoing curative treatment for head and neck cancer. Int J Oral Maxillofac Surg 2015; 44:292-6. [DOI: 10.1016/j.ijom.2014.12.009] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2014] [Revised: 11/03/2014] [Accepted: 12/10/2014] [Indexed: 11/16/2022]
|
117
|
Quinn MK, Gnan N, James S, Ninarello A, Sciortino F, Zaccarelli E, McManus JJ. How fluorescent labelling alters the solution behaviour of proteins. Phys Chem Chem Phys 2015; 17:31177-87. [DOI: 10.1039/c5cp04463d] [Citation(s) in RCA: 39] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The impact of adding a fluorescent dye to a protein is examined using protein phase diagrams and numerical simulations. The addition of the dye is the equivalent of adding a large attractive patch to the surface of the protein, which results in significant changes to the protein solution behaviour.
Collapse
|
118
|
Hind CK, Carter MJ, Harris CL, Chan HTC, James S, Cragg MS. Role of the pro-survival molecule Bfl-1 in melanoma. Int J Biochem Cell Biol 2014; 59:94-102. [PMID: 25486183 DOI: 10.1016/j.biocel.2014.11.015] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2014] [Revised: 11/11/2014] [Accepted: 11/28/2014] [Indexed: 11/16/2022]
Abstract
Bfl-1 is a pro-survival Bcl-2 family member overexpressed in a subset of chemoresistant tumours, including melanoma. Here, we characterised the expression and regulation of Bfl-1 in normal and malignant melanocytes and determined its role in protecting these cells from chemotherapy-induced apoptosis. Bfl-1 was mitochondrially resident in both resting and apoptotic cells and experienced regulation by the proteasome and NFκB pathways. siRNA-mediated knockdown enhanced sensitivity towards various relevant drug treatments, with forced overexpression of Bfl-1 protective. These findings identify Bfl-1 as a contributor towards therapeutic resistance in melanoma cells and support the use of NFκB inhibitors alongside current treatment strategies.
Collapse
|
119
|
Kristensen SD, Laut KG, Fajadet J, Kaifoszova Z, Kala P, Di Mario C, Wijns W, Clemmensen P, Agladze V, Antoniades L, Alhabib KF, De Boer MJ, Claeys MJ, Deleanu D, Dudek D, Erglis A, Gilard M, Goktekin O, Guagliumi G, Gudnason T, Hansen KW, Huber K, James S, Janota T, Jennings S, Kajander O, Kanakakis J, Karamfiloff KK, Kedev S, Kornowski R, Ludman PF, Merkely B, Milicic D, Najafov R, Nicolini FA, No c M, Ostojic M, Pereira H, Radovanovic D, Sabate M, Sobhy M, Sokolov M, Studencan M, Terzic I, Wahler S, Widimsky P. Corrigendum to: Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries. Eur Heart J 2014. [DOI: 10.1093/eurheartj/ehu333] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
120
|
Janzon M, James S, Cannon CP, Storey RF, Mellström C, Nicolau JC, Wallentin L, Henriksson M. Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy. Heart 2014; 101:119-25. [PMID: 25227704 PMCID: PMC4316918 DOI: 10.1136/heartjnl-2014-305864] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/19/2023] Open
Abstract
Objective To investigate the cost effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes (ACS) in the Platelet Inhibition and Patient Outcomes (PLATO) study who were scheduled for non-invasive management. Methods A previously developed cost effectiveness model was used to estimate long-term costs and outcomes for patients scheduled for non-invasive management. Healthcare costs, event rates and health-related quality of life under treatment with either ticagrelor or clopidogrel over 12 months were estimated from the PLATO study. Long-term costs and health outcomes were estimated based on data from PLATO and published literature sources. To investigate the importance of different healthcare cost structures and life expectancy for the results, the analysis was carried out from the perspectives of the Swedish, UK, German and Brazilian public healthcare systems. Results Ticagrelor was associated with lifetime quality-adjusted life-year (QALY) gains of 0.17 in Sweden, 0.16 in the UK, 0.17 in Germany and 0.13 in Brazil compared with generic clopidogrel, with increased healthcare costs of €467, €551, €739 and €574, respectively. The cost per QALY gained with ticagrelor was €2747, €3395, €4419 and €4471 from a Swedish, UK, German and Brazilian public healthcare system perspective, respectively. Probabilistic sensitivity analyses indicated that the cost per QALY gained with ticagrelor was below conventional threshold values of cost effectiveness with a high probability. Conclusions Treatment of patients with ACS scheduled for 12 months’ non-invasive management with ticagrelor is associated with a cost per QALY gained below conventional threshold values of cost effectiveness compared with generic clopidogrel. Trial registration number NCT000391872.
Collapse
|
121
|
Sattar A, Saleem A, Pettorini B, Pizer B, Bhatti I, Narenthiran G, Mallucci C, Hoffmann A, Gebhardt U, Sterkenburg A, Warmuth-Metz M, Muller HL, Postma FP, Hoffmann A, Gebhardt U, Muller HL, Hoffmann A, Warmuth-Metz M, Gebhardt U, Pietsch T, Pohl F, Kortmann RD, Calaminus G, Muller HL, Sterkenburg AS, Hoffmann A, Gebhardt U, Muller HL, Muller HL, Gebhardt U, Faldum A, Warmuth-Metz M, Pietsch T, Pohl F, Calaminus G, Perelberg D, Morillon P, Ederies A, Aquilina K, Dorward N, Michalski A, Hargrave D, Chang YC, Bozorgi N, James S, Korbonits M, Drake W, Akker S, Mallucci C, Pizer B, Blair J, Kamaly I, Clayton P, Spoudeas H, Wisoff J, Elliott R, Gump J, Donson A, Birks D, Handler M, Foreman N, Hankinson T. CRANIOPHARYNGIOMA. Neuro Oncol 2014. [DOI: 10.1093/neuonc/nou067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
122
|
McNamara RL, Chung SC, Jernberg T, Holmes D, Roe M, Timmis A, James S, Deanfield J, Fonarow GC, Peterson ED, Jeppsson A, Hemingway H. International comparisons of the management of patients with non-ST segment elevation acute myocardial infarction in the United Kingdom, Sweden, and the United States: The MINAP/NICOR, SWEDEHEART/RIKS-HIA, and ACTION Registry-GWTG/NCDR registries. Int J Cardiol 2014; 175:240-7. [PMID: 24882696 PMCID: PMC4112832 DOI: 10.1016/j.ijcard.2014.04.270] [Citation(s) in RCA: 51] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/29/2014] [Accepted: 04/30/2014] [Indexed: 01/29/2023]
Abstract
Objectives To compare management of patients with acute non-ST segment elevation myocardial infarction (NSTEMI) in three developed countries with national ongoing registries. Background Results from clinical trials suggest significant variation in care across the world. However, international comparisons in “real world” registries are limited. Methods We compared the use of in-hospital procedures and discharge medications for patients admitted with NSTEMI from 2007 to 2010 using the unselective MINAP/NICOR [England and Wales (UK); n = 137,009], the unselective SWEDEHEART/RIKS-HIA (Sweden; n = 45,069), and the selective ACTION Registry-GWTG/NCDR [United States (US); n = 147,438] clinical registries. Results Patients enrolled among the three registries were generally similar except those in the US who were younger but had higher rates of smoking, diabetes, hypertension, prior heart failure, and prior MI than in Sweden or in UK. Angiography and percutaneous coronary intervention (PCI) were performed more often in the US (76% and 44%) and Sweden (65% and 42%) relative to the UK (32% and 22%). Discharge betablockers were also prescribed more often in the US (89%) and Sweden (89%) than in the UK (76%). In contrast, discharge statins, angiotensin converting enzyme inhibitors/angiotensin receptor blockers (ACEI/ARB), and dual antiplatelet agents (among those not receiving PCI) were higher in the UK (92%, 79%, and 71%) than in the US (85%, 65%, 41%) and Sweden (81%, 69%, and 49%). Conclusions The care for patients with NSTEMI differed substantially among the three countries. These differences in care among countries provide an opportunity for future comparative effectiveness research as well as identify opportunities for global quality improvement.
Collapse
|
123
|
Hickey BA, Towriss C, Baxter G, Yasso S, James S, Jones A, Howes J, Davies P, Ahuja S. Early experience of MAGEC magnetic growing rods in the treatment of early onset scoliosis. EUROPEAN SPINE JOURNAL : OFFICIAL PUBLICATION OF THE EUROPEAN SPINE SOCIETY, THE EUROPEAN SPINAL DEFORMITY SOCIETY, AND THE EUROPEAN SECTION OF THE CERVICAL SPINE RESEARCH SOCIETY 2014; 23 Suppl 1:S61-5. [PMID: 24413746 DOI: 10.1007/s00586-013-3163-0] [Citation(s) in RCA: 90] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/01/2013] [Revised: 12/30/2013] [Accepted: 12/31/2013] [Indexed: 12/29/2022]
Abstract
PURPOSE Magnetically controlled growing rod systems have been introduced over recent years as an alternative to traditional growing rods for management of early onset scoliosis. The purpose of this paper is to report our early experience of a magnetically controlled growing rod system (MAGEC, Ellipse). METHODS Review of pre-operative, postoperative and follow-up Cobb angles and spinal growth in case series of eight patients with a minimum 23 months' follow-up (23-36 months). RESULTS A total of six patients had dual rod constructs implanted and two patients received single-rod constructs. Four patients had MAGEC rods as a primary procedure. Four were revisions from other systems. Mean age at surgery in the primary group was 4.5 years (range 3.9-6.9). In patients who had MAGEC as a primary procedure, mean pre-operative Cobb angle was 74° (63-94), with postoperative Cobb angle of 42° (32-56) p ≤ 0.001 (43% correction). Mean Cobb angle at follow-up was 42° (35-50). Spinal growth rate was 6 mm/year. One sustained proximal screw pull out. A final patient sustained a rod fracture. Mean age at surgery in the revision group was 10.9 years (range 9-12.6). Mean pre-operative Cobb angle was 45° (34-69). Postoperative Cobb angle was 42° (33-63) (2% correction). Mean Cobb angle at follow-up was 44° (28-67). Mean spinal growth rate was 12 mm/year. Two patients developed loss of distraction. CONCLUSION MAGEC growing rod system effectively controls early onset scoliosis when used as either a primary or revision procedure. Although implant-related complications are not uncommon, the avoidance of multiple surgeries following implantation is beneficial compared with traditional growing rod systems.
Collapse
|
124
|
Edwards N, Gaw N, Giles O, Harkness A, Jack A, James S, Leitch L, Long J, Lyness R, McDonald C, Miller E, Murdoch P, Peden N, Smith L, Trueland J, Ward D. RCPE UK consensus conference on 'Acute medicine: improving quality of care through effective patient flow--it's everyone's business!'. J R Coll Physicians Edinb 2013; 43:316-7. [PMID: 24350315 DOI: 10.4997/jrcpe.2013.410] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
|
125
|
Cochereau J, Leboucq N, James S, Coubes P, Bonafe A, Roujeau T. Intérêts de l’IRM dans le suivi des ventriculocisternostomies. Neurochirurgie 2013. [DOI: 10.1016/j.neuchi.2013.10.081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|